lifestyle.celebhomes.net
Home
Sample Page
Author:
Pyxis Oncology
Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
May 14, 2026
Pyxis Oncology to Participate in Upcoming Investor Conferences
May 13, 2026
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
May 7, 2026
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
April 17, 2026
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 23, 2026
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
February 3, 2026